Huntington's is a fairly devastating neuro-degenerative disease. This condition is well studied and is, at present, incurable. It is a brain disorder that damages some specific types of neurons, leading to degeneration in several parts of the brain causing them to lose their function. This results in uncontrolled movements, loss of intellectual abilities and behavioral disturbances. Since the mutation causes have been discovered, there have been several important advancements in understanding the cellular and molecular agitations. This book consists of current knowledge on a wide variety of...
Huntington's is a fairly devastating neuro-degenerative disease. This condition is well studied and is, at present, incurable. It is a brain disorder ...
This book gives an extensive overview on the pathogenesis and diagnosis of Alzheimer's disease. Over 6 million Europeans, out of which more than a quarter of people who are over the age of 85 and 10% who are over the age of 65, have been affected by Alzheimer's Dementia (AD). Given the steady aging of European societies, cognitive decline and dementia have grown into a crucial health problem with a great socioeconomic effect on patients, their caregivers and families, society, and national health care policy. The amount of people with dementia is estimated to double by 2030 and further...
This book gives an extensive overview on the pathogenesis and diagnosis of Alzheimer's disease. Over 6 million Europeans, out of which more than a qua...
Huntington's is a fairly devastating neuro-degenerative disease. This condition is well studied and is, at present, incurable. It is a brain disorder that damages some specific types of neurons, leading to degeneration in several parts of the brain causing them to lose their function. This results in uncontrolled movements, loss of intellectual abilities and behavioral disturbances. Since the mutation causes have been discovered, there have been several important advancements in understanding the cellular and molecular agitations. It will help clinicians, health care providers, researchers...
Huntington's is a fairly devastating neuro-degenerative disease. This condition is well studied and is, at present, incurable. It is a brain disorder ...
Myasthenia gravis is a rare chronic autoimmune disease. It is currently a cureless antibody-mediated autoimmune disorder characterized by generalized voluntary skeletal muscle weakness. The root of the weakness is a flaw at the neuromuscular junction level, in which autoimmune antibodies obstruct the receptors accountable for commencing muscular contraction. The literal meaning of myasthenia gravis from its Latin and Greek etymological origins is "grave muscle weakness." Luckily, developments in modern medicine have resulted in a decline of the truly "grave" consequences for those inflicted...
Myasthenia gravis is a rare chronic autoimmune disease. It is currently a cureless antibody-mediated autoimmune disorder characterized by generalized ...
This book is a compilation of various topics regarding disorders of nerve and muscle, with a range of well written and significant chapters discussing precise categories of neuromuscular diseases. The anticipated focus on comprehending the implications, analysis, and handling of the precise muscle and nerve diseases has been achieved. This book contains an essential preliminary chapter and a variety of topics, well-summarized, making it a good suggestion manual and an aid to treatment.
This book is a compilation of various topics regarding disorders of nerve and muscle, with a range of well written and significant chapters discussing...
Over 6 million Europeans, out of which more than a quarter of people are over the age of 85 and 10% are over the age of 65, have been affected by Alzheimer's Dementia (AD). Given the steady aging of European societies, cognitive decline and dementia have grown into a crucial health problem with a great socioeconomic effect on patients, their caregivers and families, society, and national health care systems. The number of people with dementia is estimated to double by 2030 and further increase by 2050. There is a critical requirement for creative methods to boost understanding of pathological...
Over 6 million Europeans, out of which more than a quarter of people are over the age of 85 and 10% are over the age of 65, have been affected by Alzh...